Senyo Health App - Comorbid Alcohol Use Disorder Treatment in Individuals With Bipolar Disorder Using a Telehealth Collaborative Care Platform
Mayo Clinic
Summary
The purpose of this study is to examine the effectiveness of a digital integrated behavioral health (IBH) platform in improving alcohol use outcomes, including treatment retention and substance use frequency and severity in patients with Bipolar Disorder.
Eligibility
- Age range
- 18+ years
- Sex
- All
- Healthy volunteers
- No
Inclusion Criteria: 1. Age\>=18 years; 2. History of bipolar I disorder, bipolar II disorder, or schizoaffective disorder of the bipolar type. Can be clinical diagnosis 3. Ability to read, write, and understand English; 4. Minimum DAST (1+) or AUDIT-C score (3+) 5. Access and willingness to use a mobile device for asynchronous (text) and synchronous (video) engagement with care; 6. Eligibility determined by ASAM Assessment as completed by a LADC. Exclusion Criteria: 1. Inability to actively participate in and learn from psychotherapeutic interaction based on clinical evaluation and clinical…
Interventions
- OtherSenyo Health App
The Senyo Health app includes asynchronous cognitive behavioral therapy (CBT) modules, contingency management, behavioral activation, and an interface to interact with the care manager for support in treating the comorbidities of bipolar disorder and substance use disorder. Patients will engage with the app daily and have weekly check-in visits with the care manager. After the initial 12 week intervention phase, subjects will be followed for 1 year.
Location
- Mayo Clinic in RochesterRochester, Minnesota